Clinical Trial Update: A Study of Brain Receptor Occupancy in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study by Eli Lilly evaluating brain receptor occupancy in healthy subjects; the study concerns Alcohol Dependence and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alcohol Dependence | Phase 1 | Status: COMPLETED